Quantcast

Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:
Welcome, Guest. Please login or register.
September 21, 2014, 08:29:35 PM

Login with username, password and session length


Members
Stats
  • Total Posts: 639715
  • Total Topics: 48558
  • Online Today: 210
  • Online Ever: 585
  • (January 07, 2014, 02:31:47 PM)
Users Online

Welcome


Welcome to the POZ/AIDSmeds Community Forums, a round-the-clock discussion area for people with HIV/AIDS, their friends/family/caregivers, and others concerned about HIV/AIDS.  Click on the links below to browse our various forums; scroll down for a glance at the most recent posts; or join in the conversation yourself by registering on the left side of this page.

Privacy Warning:  Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If you are HIV positive and disclose this in our forums, then it is almost the same thing as telling the whole world (or at least the World Wide Web). If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.

  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.

  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.

  • Forums members must behave at all times with respect and honesty. Posting guidelines, including time-out and banning policies, have been established by the moderators of these forums. Click here for “Am I Infected?” posting guidelines. Click here for posting guidelines pertaining to all other POZ/AIDSmeds community forums.

  • We ask all forums members to provide references for health/medical/scientific information they provide, when it is not a personal experience being discussed. Please provide hyperlinks with full URLs or full citations of published works not available via the Internet. Additionally, all forums members must post information which are true and correct to their knowledge.

  • Product advertisement—including links; banners; editorial content; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from POZ.

To change forums navigation language settings, click here (members only), Register now

Para cambiar sus preferencias de los foros en español, haz clic aquí (sólo miembros), Regístrate ahora

Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: TAT Monoclonal Antibody Trial Fails - Will Try Higher Dosage  (Read 2844 times)

0 Members and 1 Guest are viewing this topic.

Offline MitchMiller

  • Member
  • Posts: 479
 BioInvent reports the result from the clinical study in HIV
[2006-05-29 8:45]

Lund, Sweden: BioInvent International AB (SAX:BINV) announces today that the results from the clinical phase I/IIa trial of BI-201, its drug candidate for the treatment of HIV infection, shows the drug to be well tolerated but shows no reduction of the HIV levels with the investigated dosing. Based on the recommendation by the investigators BioInvent consider to amend the study protocol to include more patients on higher doses than was used so far.

"By adding more patients on higher doses to the study we hope to achieve in addition to a good safety profile the goal of decreased virus levels. Given that we obtain the necessary regulatory approvals our judgement is that the results will be available before yearend." comments BioInvent“s CEO Svein Mathisen.

- END -


For more information
BioInvent International AB
Svein Mathisen
President and CEO
Phone: +46 (0)46 286 85 67
Mobile: 046 (0)708 97 82 13
E-mail: svein.mathisen@bioinvent.com  >:( >:(

Offline J220

  • Member
  • Posts: 587
Re: TAT Monoclonal Antibody Trial Fails - Will Try Higher Dosage
« Reply #1 on: June 14, 2006, 10:10:16 PM »
Too bad....let's hope a higher dosage is anti-viral. I wonder what models they used before the started the trial? Anyone know about this one?
"Hope is my philosophy
Just needs days in which to be
Love of Life means hope for me
Born on a New Day" - John David

 


Terms of Membership for these forums
 

© 2014 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.